Global Human Milk Oligosaccharides (HMO) Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Human Milk Oligosaccharides (HMO) Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

According to APO Research, The global Human Milk Oligosaccharides (HMO) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO).
The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Dextra Laboratories
Human Milk Oligosaccharides (HMO) segment by Type

2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Human Milk Oligosaccharides (HMO) segment by Application

Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Human Milk Oligosaccharides (HMO) by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2019-2030)
1.3 Human Milk Oligosaccharides (HMO) Market by Type
1.3.1 2'-FL & 3-FL
1.3.2 Sialyllactose
1.3.3 LNT & LNnT
1.4 Global Human Milk Oligosaccharides (HMO) Market Size by Type
1.4.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Type (2019-2030)
1.4.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Human Milk Oligosaccharides (HMO) Industry Trends
2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Human Milk Oligosaccharides (HMO) Revenue (2019-2024)
3.2 Global Top Players by Human Milk Oligosaccharides (HMO) Sales (2019-2024)
3.3 Global Top Players by Human Milk Oligosaccharides (HMO) Price (2019-2024)
3.4 Global Human Milk Oligosaccharides (HMO) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Milk Oligosaccharides (HMO) Key Company Manufacturing Sites & Headquarters
3.6 Global Human Milk Oligosaccharides (HMO) Company, Product Type & Application
3.7 Global Human Milk Oligosaccharides (HMO) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2023
3.8.3 2023 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3
4 Human Milk Oligosaccharides (HMO) Regional Status and Outlook
4.1 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size by Region
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2019-2024)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2019-2024)
4.2.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region
4.3.1 Global Human Milk Oligosaccharides (HMO) Sales in Volume by Region (2025-2030)
4.3.2 Global Human Milk Oligosaccharides (HMO) Sales in Value by Region (2025-2030)
4.3.3 Global Human Milk Oligosaccharides (HMO) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Human Milk Oligosaccharides (HMO) by Application
5.1 Human Milk Oligosaccharides (HMO) Market by Application
5.1.1 Infant Formula
5.1.2 Functional Food & Beverages
5.1.3 Food/Medical Supplements
5.1.4 Others
5.2 Global Human Milk Oligosaccharides (HMO) Market Size by Application
5.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Overview by Application (2019-2030)
5.2.2 Global Human Milk Oligosaccharides (HMO) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Abbott
6.1.1 Abbott Comapny Information
6.1.2 Abbott Business Overview
6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
6.1.5 Abbott Recent Developments
6.2 Inbiose
6.2.1 Inbiose Comapny Information
6.2.2 Inbiose Business Overview
6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
6.2.5 Inbiose Recent Developments
6.3 Glycom
6.3.1 Glycom Comapny Information
6.3.2 Glycom Business Overview
6.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
6.3.5 Glycom Recent Developments
6.4 Chr. Hansen (Jennewein)
6.4.1 Chr. Hansen (Jennewein) Comapny Information
6.4.2 Chr. Hansen (Jennewein) Business Overview
6.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
6.4.5 Chr. Hansen (Jennewein) Recent Developments
6.5 Elicityl SA
6.5.1 Elicityl SA Comapny Information
6.5.2 Elicityl SA Business Overview
6.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
6.5.5 Elicityl SA Recent Developments
6.6 ZuChem
6.6.1 ZuChem Comapny Information
6.6.2 ZuChem Business Overview
6.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
6.6.5 ZuChem Recent Developments
6.7 Dextra Laboratories
6.7.1 Dextra Laboratories Comapny Information
6.7.2 Dextra Laboratories Business Overview
6.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
6.7.5 Dextra Laboratories Recent Developments
7 North America by Country
7.1 North America Human Milk Oligosaccharides (HMO) Sales by Country
7.1.1 North America Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024)
7.1.3 North America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2025-2030)
7.2 North America Human Milk Oligosaccharides (HMO) Market Size by Country
7.2.1 North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024)
7.2.3 North America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country
8.1.1 Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024)
8.1.3 Europe Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2025-2030)
8.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
8.2.1 Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024)
8.2.3 Europe Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country
9.1.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country
9.2.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country
10.1.1 Latin America Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024)
10.1.3 Latin America Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2025-2030)
10.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country
10.2.1 Latin America Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024)
10.2.3 Latin America Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country
11.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country
11.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
12.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Milk Oligosaccharides (HMO) Production Mode & Process
12.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Milk Oligosaccharides (HMO) Distributors
12.2.3 Human Milk Oligosaccharides (HMO) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings